Last reviewed · How we verify
TJ101 injection Reference Product — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
TJ101 injection Reference Product (TJ101 injection Reference Product) — TJ Biopharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TJ101 injection Reference Product TARGET | TJ101 injection Reference Product | TJ Biopharma Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TJ101 injection Reference Product CI watch — RSS
- TJ101 injection Reference Product CI watch — Atom
- TJ101 injection Reference Product CI watch — JSON
- TJ101 injection Reference Product alone — RSS
Cite this brief
Drug Landscape (2026). TJ101 injection Reference Product — Competitive Intelligence Brief. https://druglandscape.com/ci/tj101-injection-reference-product. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab